Freitag, 31. Oktober 2014

Abilify is the preferred brand for the treatment of Schizophrenia

Abilify is found to be the preferred brand for the treatment of Schizophrenia according to surveyed U.S. Psychiatrists and Payers



via Marketing - United States - Latest News http://ift.tt/1tIOLvz

Keine Kommentare:

Kommentar veröffentlichen